ARTICLE | Clinical News
Hexvix: Began Phase III trial enrollment
October 8, 2001 7:00 AM UTC
PhotoCure ASA (OSE:PHO), Oslo, Norway Product: Hexvix Business: Diagnostics/Imaging Therapeutic category: Test Target: NA Description: Fluorescence cystoscopy Indication: Detect bladder cancer Endpoi...